ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

In Brief: McDonnell Foundation Selects Five For $400,000 Fellowships; Alberts, Verma Picked For Awards

January 4, 1991

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

NCI Programs:Institute Informs Public About Thyroid Cancer Risk From Fallout.

January 3, 2003

MSK, Fox Chase Volunteer to Limit Their Core Grants To Let Others Grow

June 29, 1990